Annexin V has a calcium-dependent binding affinity for anionic phospholipids and activated platelets, and prevents prothrombinase activity. We investigated the clinical significance of IgG anti-annexin V antibodies in patients with SLE. The study population consisted of 140 patients with SLE. Sera w
Anti-annexin V antibody in systemic lupus erythematosus patients with lupus anticoagulant and/or anticardiolipin antibody
β Scribed by Dr. Juzo Matsuda; Noriko Saitoh; Kengo Gohchi; Moritaka Gotoh; And Miyo Tsukamoto
- Publisher
- John Wiley and Sons
- Year
- 1994
- Tongue
- English
- Weight
- 185 KB
- Volume
- 47
- Category
- Article
- ISSN
- 0361-8609
No coin nor oath required. For personal study only.
β¦ Synopsis
Abstract
We investigated antiβannexin V antibody (aANX) in patients with systemic lupus erytheβmatosus (SLE), and correlated to positivity with lupus anticoagulant (LA)/anticardiolipin antibody (aCL). aANX was positive in 12/47 SLE patients (26%), including 7 with Ξ²~2~βglycoprotein 1 (GPl)βdependent aANX. The positivity of aANX was higher in patients with aCL (19%) and LA/aCL (50%) than in those without LA/aCL (10%). From these results, it is concluded that aANX is an autoantibody closely related to LA/aCL, and can be a possible new risk marker for thrombosis. Β© 1994 WileyβLiss, Inc.
π SIMILAR VOLUMES
## Abstract Twentyβone sera from 11 patients with systemic lupus erythematosus were titrated with ^125^Iβssβcalf thymus DNA to determine their maximum capacity to bind DNA. Only five sera were capable of binding > 90% of the input DNA. The remaining sixteen sera showed maximum DNA binding levels be